operating performance for 31 December 2017 as the following. Key Financial Information on 31 December 2017 , 2016 (Unit : thousands) Statements of Income Separate financial statements December 31, 2017
, Thailand, made the following resolutions pertaining to the important agenda as follows: 1) Liquidation of Advanced Biochemical Europe Resolved to approve the liquidation of Advanced Biochemical Europe
million for the year ended 31th December 2017 and 2016 respectively. The decrease of Baht 31.84 million in the loss is mainly due to the following. 1. A increment in the Group’s revenue 5.45% or Baht 12.78
Chain Hospital Public Company Limited (the “Company”) No.2/2018, held on 26 February 2018 has passed the resolution to approve the related party transaction as the following details: Approval of Asset
of Bangkok Chain Hospital Public Company Limited (the “Company”) No.2/2018, held on 26 February 2018 has passed the resolution to approve the related party transaction as the following details
or 8.4% as a result of higher sales of suites following the completion of the Authors’ and Garden Wings renovation in April 2016, Food & Beverage revenue increased by Baht 9.5 million or 1.1% and Other
, Section 34, Section 36, Section 41, Section 43 and Section 45 of the Constitution of the Kingdom of Thailand so permit by virtue of law, the Capital Market Supervisory Board issues the following regulations
, Section 36, Section 41, Section 43 and Section 45 of the Constitution of the Kingdom of Thailand so permit by virtue of law, the Capital Market Supervisory Board issues the following regulations: Clause 1
Capital Market Supervisory Board hereby issues the following regulations: Clause 1 Notification of the Capital Market Supervisory Board No. TorKhor. 56/2552 Re: Rules, Conditions and Procedures for